xanthinol niacinate has been researched along with Fetal Growth Restriction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balika, IuD; Fursova, ZK; Mamedalieva, NM; Razumovskaia, IN | 1 |
| Korte, W; Kugener, H; Senft, HH | 1 |
| Kiełkowski, A; Majczyńska, W; Uszyński, M; Uszyński, W | 1 |
3 other study(ies) available for xanthinol niacinate and Fetal Growth Restriction
| Article | Year |
|---|---|
[Characteristics of lymphocytic enzyme status of the newborn after metabolic therapy of pregnant women].
Topics: Abortion, Habitual; Benzenesulfonates; Dipyridamole; Estradiol Congeners; Female; Fetal Growth Retardation; Fetal Hypoxia; Glycerolphosphate Dehydrogenase; Humans; Hypnotics and Sedatives; Infant, Newborn; Lymphocytes; Parasympatholytics; Physical Therapy Modalities; Pregnancy; Succinate Dehydrogenase; Vasodilator Agents; Xanthinol Niacinate | 1995 |
[Pathology and clinical aspects of retarded child development. Diagnosis and therapy of defective development].
Topics: Betamethasone; Birth Weight; Drug Therapy, Combination; Female; Fenoterol; Fetal Growth Retardation; Heparin; Humans; Infant, Newborn; Placental Insufficiency; Pregnancy; Ultrasonics; Uterine Contraction; Xanthinol Niacinate | 1977 |
[Chronic stimulation of the fibrinolytic system as supplementary treatment of intrauterine fetal hypotrophy].
Topics: Drug Therapy, Combination; Female; Fetal Growth Retardation; Fibrinolysis; Fibrinolytic Agents; Humans; Methandrostenolone; Pregnancy; Theophylline; Time Factors; Xanthinol Niacinate | 1988 |